Skip to main content
. 2020 Jul 15;91:104185. doi: 10.1016/j.archger.2020.104185

Table 2.

Laboratory and radiographic findings of older patients with COVID-19 on admission.

All patients (n = 312) Non-severe (n = 207) Severe (n = 105) p value
White blood cell count, ×109/L 7.5 ± 4.3 6.8 ± 3.9 12.1 ± 4.5 0.031
Neutrophil count, ×109/L 6.1 ± 3.6 5.7 ± 3.5 10.3 ± 5.1 0.039
Lymphocyte count, ×109/L 1.1 ± 0.4 1.9 ± 0.6 0.8 ± 0.4 0.012
 <1.1, n(%) 191(61.2) 109(52.7) 82(78.1) 0.029
Haemoglobin, g/L 120.3 ± 28.4 124.5 ± 32.1 119.4 ± 25.7 0.387
Platelet count, ×109/L 205.3 ± 85.6 233.7 ± 92.6 157.4 ± 95.3 0.002
 <125, n(%) 64(20.5) 10(4.83) 54(51.4) 0.001
Prothrombin time, s 13.5 ± 4.9 12.7 ± 5.4 14.8 ± 4.5 0.010
Activated partial thromboplastin time, s 35.4 ± 6.3 33.9 ± 5.6 38.7 ± 7.8 0.028
D-dimer, mg/L 0.7 ± 0.6 0.5 ± 0.3 4.8 ± 2.1 0.018
Alanine transaminase, U/L 40.5 ± 20.5 31.6 ± 18.9 48.2 ± 20.1 0.009
Aspartate transaminase, U/L 45.2 ± 30.6 40.6 ± 22.7 50.3 ± 29.8 0.005
Total bilirubin, mmol/L 18.7 ± 10.5 13.7 ± 9.9 21.2 ± 9.6 0.035
Creatinine, μmol/L 64.7 ± 46.7 52.4 ± 40.2 91.3 ± 41.3 0.003
 >133, n(%) 21(6.73) 4(1.93) 17(16.2) 0.016
Potassium, mmol/L 4.0 ± 1.1 3.9 ± 0.8 4.2 ± 1.0 0.535
Sodium, mmol/L 141.1 ± 9.2 143.0 ± 8.3 139.8 ± 7.9 0.457
Creatine kinase, U/L 85.6 ± 46.7 82.3 ± 38.7 101.2 ± 32.1 0.612
Lactate dehydrogenase, U/L 200.2 ± 61.2 150.4 ± 58.4 220.1 ± 42.1 0.652
Hypersensitive troponin I, pg/mL 8.6 ± 4.3 7.5 ± 5.4 15.3 ± 3.6 0.025
Procalcitonin, ng/mL 0.25 ± 0.12 0.16 ± 0.11 0.33 ± 0.20 0.013
Serum ferritin, μg/L 702.3 ± 200.4 665.4 ± 86.5 1203.1 ± 126.7 0.027
Interleukin-6, pg/mL 7.8 ± 4.6 6.9 ± 3.8 18.7 ± 4.5 0.001
Ground-glass opacity, n(%) 251(80.4) 170(82.1) 81(77.1) 0.052
Consolidation, n(%) 163(52.2) 70(43.5) 93(88.6) 0.005
Bilateral pulmonary infiltration, n(%) 231(74.0) 156(50.0) 75(71.4) 0.042